Analysis of Maspin Expression in Invasive Ductal Carcinoma of the Breast on Stages IIA and IIIB

Mammary Serine Protease Inhibitor (maspin) is a tumor suppressor gene, a member of the serine protease inhibitor (serpin) family that works by inhibiting motility of cell movement, invasion and metastasis. Maspin expression is expected to be a prognostic factor as well as a predictive factor in mamm...

Full description

Bibliographic Details
Main Authors: Arif Satria Hardika, Dyah Fauziah
Format: Article
Language:English
Published: Universitas Airlangga 2018-04-01
Series:Folia Medica Indonesiana
Subjects:
Online Access:https://e-journal.unair.ac.id/FMI/article/view/8043
id doaj-b046c6b91e4a4ddcb232e4ac8c6f5646
record_format Article
spelling doaj-b046c6b91e4a4ddcb232e4ac8c6f56462020-11-24T20:43:39ZengUniversitas AirlanggaFolia Medica Indonesiana2355-83932599-056X2018-04-015416910.20473/fmi.v54i1.80434383Analysis of Maspin Expression in Invasive Ductal Carcinoma of the Breast on Stages IIA and IIIBArif Satria Hardika0Dyah Fauziah1Department of Anatomic Pathology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo Hospital, SurabayaDepartment of Anatomic Pathology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo Hospital, SurabayaMammary Serine Protease Inhibitor (maspin) is a tumor suppressor gene, a member of the serine protease inhibitor (serpin) family that works by inhibiting motility of cell movement, invasion and metastasis. Maspin expression is expected to be a prognostic factor as well as a predictive factor in mammary tumors. However, in some recent studies, maspin has a variety of expressions. Although it is known that no maspine appears as an indicator of tumor progression and metastasis, recent study has shown that maspine expression is associated with an aggressive phenotype of breast cancer and with a poor prognosis. Correlations between maspine expression and poor prognosis have also been reported in pancreatic, ovarian, thyroid, bladder and lung cancers. Knowledge of the expression and role of this maspin as well as its relationship with the pathogenesis of breast invasive ductal carcinoma is still small. The aim of this study was to look at differences in maspin expression in breast-invasive ductal carcinoma of stage IIA and stage IIIB groups. This research method used analytic observational research with cross sectional approach. The samples were invasive carcinoma of NST paraffin at the Department of Anatomic Pathology of Dr Soetomo Hospital, Surabaya, from January to December 2015. Thirty samples were divided into two groups, namely stage IIA and stage IIIB groups and immunohistochemical examination with maspin antibody was carried out. The difference of maspin expression in stage IIA and stage IIIB was analyzed using Mann-Whitney statistic test. There were significant differences in maspin expression between stage IIA and stage IIIB groups, where stage IIA has a high maspin expression rather than stage IIIB.https://e-journal.unair.ac.id/FMI/article/view/8043Invasive breast cancer stages IIA and IIIBmaspin
collection DOAJ
language English
format Article
sources DOAJ
author Arif Satria Hardika
Dyah Fauziah
spellingShingle Arif Satria Hardika
Dyah Fauziah
Analysis of Maspin Expression in Invasive Ductal Carcinoma of the Breast on Stages IIA and IIIB
Folia Medica Indonesiana
Invasive breast cancer stages IIA and IIIB
maspin
author_facet Arif Satria Hardika
Dyah Fauziah
author_sort Arif Satria Hardika
title Analysis of Maspin Expression in Invasive Ductal Carcinoma of the Breast on Stages IIA and IIIB
title_short Analysis of Maspin Expression in Invasive Ductal Carcinoma of the Breast on Stages IIA and IIIB
title_full Analysis of Maspin Expression in Invasive Ductal Carcinoma of the Breast on Stages IIA and IIIB
title_fullStr Analysis of Maspin Expression in Invasive Ductal Carcinoma of the Breast on Stages IIA and IIIB
title_full_unstemmed Analysis of Maspin Expression in Invasive Ductal Carcinoma of the Breast on Stages IIA and IIIB
title_sort analysis of maspin expression in invasive ductal carcinoma of the breast on stages iia and iiib
publisher Universitas Airlangga
series Folia Medica Indonesiana
issn 2355-8393
2599-056X
publishDate 2018-04-01
description Mammary Serine Protease Inhibitor (maspin) is a tumor suppressor gene, a member of the serine protease inhibitor (serpin) family that works by inhibiting motility of cell movement, invasion and metastasis. Maspin expression is expected to be a prognostic factor as well as a predictive factor in mammary tumors. However, in some recent studies, maspin has a variety of expressions. Although it is known that no maspine appears as an indicator of tumor progression and metastasis, recent study has shown that maspine expression is associated with an aggressive phenotype of breast cancer and with a poor prognosis. Correlations between maspine expression and poor prognosis have also been reported in pancreatic, ovarian, thyroid, bladder and lung cancers. Knowledge of the expression and role of this maspin as well as its relationship with the pathogenesis of breast invasive ductal carcinoma is still small. The aim of this study was to look at differences in maspin expression in breast-invasive ductal carcinoma of stage IIA and stage IIIB groups. This research method used analytic observational research with cross sectional approach. The samples were invasive carcinoma of NST paraffin at the Department of Anatomic Pathology of Dr Soetomo Hospital, Surabaya, from January to December 2015. Thirty samples were divided into two groups, namely stage IIA and stage IIIB groups and immunohistochemical examination with maspin antibody was carried out. The difference of maspin expression in stage IIA and stage IIIB was analyzed using Mann-Whitney statistic test. There were significant differences in maspin expression between stage IIA and stage IIIB groups, where stage IIA has a high maspin expression rather than stage IIIB.
topic Invasive breast cancer stages IIA and IIIB
maspin
url https://e-journal.unair.ac.id/FMI/article/view/8043
work_keys_str_mv AT arifsatriahardika analysisofmaspinexpressionininvasiveductalcarcinomaofthebreastonstagesiiaandiiib
AT dyahfauziah analysisofmaspinexpressionininvasiveductalcarcinomaofthebreastonstagesiiaandiiib
_version_ 1716819248703078400